Plasmatic levels of N-terminal pro-atrial natriuretic peptide in preeclamptic patients and healthy normotensive pregnant women. 2018

Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
Hospital Central Dr. Urquinaona, Maracaibo, Venezuela. Electronic address: sippenbauch@gmail.com.

To compare plasma N-terminal pro-atrial natriuretic peptide concentrations in preeclamptic patients and healthy normotensive pregnant women. A cases-controls study was done with 180 patients at Hospital Central Dr. Urquinaona, Maracaibo, Venezuela, that included 90 preeclamptic patients (group A; cases) and 90 healthy normotensive pregnant women selected with the same age and body mass index similar to group A (group B; controls). Blood samples were collected one hour after admission and prior to administration of any medication in group A to determine plasma N-terminal pro-atrial natriuretic peptide and other laboratory parameters. Plasma N-terminal pro-atrial natriuretic peptide concentrations in group A (mean 1.01 [0.26] pg/mL) showed a significant difference when compared with patients in group B (mean 0.55 [0.07] pg/mL; P<.001]. There was no significant correlation with systolic and diastolic blood pressure values in preeclamptic patients (P=ns). A cut-off value of 0.66ng/mL had an area under the curve of 0.93, sensitivity of 87.8%, specificity of 83.3%, a positive predictive value of 84.0% and a negative predictive value of 87.2%, with a diagnostic accuracy of 85.6%. Preeclamptic patients have significantly higher concentrations of plasma N-terminal pro-atrial natriuretic peptide compared with healthy normotensive pregnant women, with high predictive values for diagnosis.

UI MeSH Term Description Entries
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011498 Protein Precursors Precursors, Protein
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
May 1996, European journal of pharmacology,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
January 2009, Indian pacing and electrophysiology journal,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
December 1990, American journal of hypertension,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
June 2011, Psychoneuroendocrinology,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
February 2005, European heart journal,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
August 2001, Clinica chimica acta; international journal of clinical chemistry,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
May 2001, Regulatory peptides,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
November 2003, American journal of obstetrics and gynecology,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
June 2015, International journal of cardiology,
Eduardo Reyna-Villasmil, and Jorly Mejia-Montilla, and Nadia Reyna-Villasmil, and Gabriel Mayner-Tresol, and Pedro Herrera-Moya, and Andreina Fernández-Ramírez, and Marta Rondón-Tapía
September 1994, Clinical science (London, England : 1979),
Copied contents to your clipboard!